Pubblicazioni

Targeting the antigen processing and presentation pathway to overcome resistance to immune checkpoint therapy

2022 - FRONTIERS IN IMMUNOLOGY

D'Amico, Silvia; Tempora, Patrizia; Melaiu, Ombretta; Lucarini, Valeria; Cifaldi, Loredana; Locatelli, Franco; Fruci, Doriana

ERAP1 Controls the Interaction of the Inhibitory Receptor KIR3DL1 With HLA-B51:01 by Affecting Natural Killer Cell Function

2021 - FRONTIERS IN IMMUNOLOGY

D'Amico, Silvia; D'Alicandro, Valerio; Compagnone, Mirco; Tempora, Patrizia; Guida, Giusy; Romania, Paolo; Lucarini, Valeria; Melaiu, Ombretta; Falco, Michela; Algeri, Mattia; Pende, Daniela; Cifaldi, Loredana; Fruci, Doriana

ERAP1 Controls the Interaction of the Inhibitory Receptor KIR3DL1 With HLA-B51:01 by Affecting Natural Killer Cell Function

2021 - FRONTIERS IN IMMUNOLOGY

Killer Ig-like receptors (kirs). their role in nk cell modulation and developments leading to their clinical exploitation

2019 - FRONTIERS IN IMMUNOLOGY

Pende, D.; Falco, M.; Vitale, M.; Cantoni, C.; Vitale, C.; Munari, E.; Bertaina, A.; Moretta, F.; Del Zotto, G.; Pietra, G.; Mingari, M. C.; Locatelli, F.; Moretta, L.

HLA Class I or Class II and Disease Association: Catch the Difference if You Can

2017 - FRONTIERS IN IMMUNOLOGY

Fiorillo, Mt; Paladini, F; Tedeschi, V; Sorrentino, R.